Table 3

Timing of discontinuing DOACs before high-risk endoscopic procedures according to creatinine clearance100

Creatinine clearance (mL/min)Timing of discontinuing DOACs before high-risk endoscopic procedures (days)
DabigatranApixaban/rivaroxaban/edoxaban
>8022
50–8032
30–5042
15–30Contraindicated2
<15ContraindicatedNot recommended